The effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease, congestive heart failure, ...

Heart disease is closely linked with obesity. Excess weight mainly accounts for the surge in deaths from cardiovascular ...

The prevalence of metabolic diseases, such as obesity, has been steadily increasing in recent years, posing a significant threat to public health. Therefore, early identification and intervention play ...

Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a ...

A new study uncovers a novel mechanism through which brown fat is transformed into heat, offering protection against ...

If you have obesity, losing even a little weight helps not only improve your overall health, but also prevent liver issues such as MASH.

A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious liver complications ...

You will be redirected to our submission process. Obesity is a severe public health problem, contributing significantly to the global non-communicable disease burden, including type 2 diabetes (T2D), ...

Gov. Jared Polis and the Colorado state legislature have the opportunity this year to pass a law to help our sickest and most ...

The condition is better measured by looking at factors like inflammation, insulin resistance, and glucose tolerance, ...

We are recommending Skye Bioscience Inc. (SKYE) as our next investment opportunity in treating metabolic disease/obesity. Skye is developing a peripheral restricted CB1 antibody — nimacimab — to treat ...